Ristocetin induces phosphorylated-HSP27 (HSPB1) release from the platelets of type 2 DM patients: Anti-platelet agent-effect on the release

It has been previously reported that HSP27 is released from platelets in type 2 diabetes mellitus (DM) patients according to phosphorylation. In the present study, we investigated the effect of ristocetin, a glycoprotein (GP)Ib/IX/V activator, on the release of HSP27 and the effect of anti-platelet...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biomed Rep
Hlavní autoři: Tokuda, Haruhiko, Kuroyanagi, Gen, Onuma, Takashi, Enomoto, Yukiko, Doi, Tomoaki, Iida, Hiroki, Otsuka, Takanobu, Ogura, Shinji, Iwama, Toru, Kojima, Kumi, Kozawa, Osamu
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2018
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5838301/
https://ncbi.nlm.nih.gov/pubmed/29541457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2018.1058
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky